• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身性神经节苷脂沉积症:β-半乳糖苷酶缺乏症。

Generalized gangliosidosis: beta-galactosidase deficiency.

作者信息

Okada S, O'Brien J S

出版信息

Science. 1968 May 31;160(3831):1002-4. doi: 10.1126/science.160.3831.1002.

DOI:10.1126/science.160.3831.1002
PMID:5647842
Abstract

A profound deficiency (10- to 30-fold) of beta-galactosidase activity was found in tissues (liver, spleen, kidney, and brain) from two patients with generalized gangliosidosis; this deficiency is demonstrated as a failure to cleave both p-nitrophenyl-beta-D-galactopyranoside and ganglioside GM(1) labeled with C(14) in the terminal galactose. We believe that this enzymic defect is responsible for the accumulation of ganglioside GM(1) and is the fundamental enzyme defect in generalized gangliosidosis.

摘要

在两名全身性神经节苷脂沉积症患者的组织(肝脏、脾脏、肾脏和大脑)中发现β-半乳糖苷酶活性严重缺乏(10至30倍);这种缺乏表现为不能切割对硝基苯基-β-D-吡喃半乳糖苷和在末端半乳糖上标记有C(14)的神经节苷脂GM(1)。我们认为这种酶缺陷是神经节苷脂GM(1)积累的原因,并且是全身性神经节苷脂沉积症的根本酶缺陷。

相似文献

1
Generalized gangliosidosis: beta-galactosidase deficiency.全身性神经节苷脂沉积症:β-半乳糖苷酶缺乏症。
Science. 1968 May 31;160(3831):1002-4. doi: 10.1126/science.160.3831.1002.
2
Beta-galactosidase in tissue culture derived from human skin and bone marrow. Enzyme defect in GM1 gangliosidosis.源自人皮肤和骨髓的组织培养中的β-半乳糖苷酶。GM1神经节苷脂贮积症中的酶缺陷。
Pediatr Res. 1969 Nov;3(6):532-7. doi: 10.1203/00006450-196911000-00002.
3
Beta-galactosidase deficiency in the hurler syndrome.黏多糖贮积症Ⅰ型中的β-半乳糖苷酶缺乏症。
N Engl J Med. 1969 Aug 14;281(7):338-43. doi: 10.1056/NEJM196908142810702.
4
GENERALIZED GANGLIOSIDOSIS: ANOTHER INBORN ERROR OF GANGLIOSIDE METABOLISM?全身性神经节苷脂沉积症:另一种神经节苷脂代谢的先天性缺陷?
Am J Dis Child. 1965 Apr;109:338-46.
5
Biochemical studies in cat and human gangliosidosis.猫和人类神经节苷脂贮积症的生化研究。
J Neurochem. 1971 Jul;18(7):1275-80. doi: 10.1111/j.1471-4159.1971.tb00226.x.
6
Enzymatic study of GM-1 gangliosidosis.GM-1神经节苷脂贮积症的酶学研究
Clin Chim Acta. 1975 Mar 24;59(3):283-90. doi: 10.1016/0009-8981(75)90003-0.
7
GM1-ganglioside accumulation and beta-galactosidase deficiency in a case of GM1-gangliosidosis (Landing disease).GM1神经节苷脂贮积症(兰丁病)一例中的GM1神经节苷脂蓄积及β-半乳糖苷酶缺乏
Clin Chim Acta. 1968 Sep;21(3):421-5. doi: 10.1016/0009-8981(68)90071-5.
8
Hexosaminidase activities in a case of systemic GM2 gangliosidosis of late infantile type.晚发性婴儿型全身性GM2神经节苷脂沉积症一例中的己糖胺酶活性
Proc Soc Exp Biol Med. 1970 Mar;133(3):997-8. doi: 10.3181/00379727-133-34613.
9
Beta-galactosidase deficiency in GM1 gangliosidosis of Friesian calves.
Res Vet Sci. 1973 Jul;15(1):139-41.
10
Leukocyte beta-galactosidase activity in the diagnosis of generalized GM 1 gangliosidosis.
Pediatrics. 1972 Mar;49(3):352-61.

引用本文的文献

1
Pediatric Genetic Dystonias: Current Diagnostic Approaches and Treatment Options.小儿遗传性肌张力障碍:当前的诊断方法与治疗选择
Life (Basel). 2025 Jun 20;15(7):992. doi: 10.3390/life15070992.
2
Infection of a β-galactosidase-deficient mouse strain with Theiler's murine encephalomyelitis virus reveals limited immunological dysregulations in this lysosomal storage disease.用泰勒氏鼠脑脊髓炎病毒感染β-半乳糖苷酶缺陷型小鼠品系,揭示了这种溶酶体贮积病中有限的免疫失调。
Front Immunol. 2025 Apr 9;16:1467207. doi: 10.3389/fimmu.2025.1467207. eCollection 2025.
3
Adeno-associated virus expressing a blood-brain barrier-penetrating enzyme improves GM1 gangliosidosis in a preclinical model.
表达一种可穿透血脑屏障的酶的腺相关病毒在临床前模型中改善了GM1神经节苷脂贮积症。
J Clin Invest. 2025 Apr 8;135(12). doi: 10.1172/JCI180724. eCollection 2025 Jun 16.
4
Imaging manifestations in infantile GM1 gangliosidosis: a rare lysosomal storage disorder: a paediatric case report.婴儿GM1神经节苷脂贮积症的影像学表现:一种罕见的溶酶体贮积症:一例儿科病例报告
BJR Case Rep. 2025 Apr 1;11(2):uaaf009. doi: 10.1093/bjrcr/uaaf009. eCollection 2025 Mar.
5
Clinical and genetic analysis of a Chinese family with GM1 gangliosidosis caused by a novel mutation in GLB1 gene.一个因GLB1基因新突变导致GM1神经节苷脂贮积症的中国家庭的临床与遗传学分析
Front Pediatr. 2025 Jan 20;13:1507098. doi: 10.3389/fped.2025.1507098. eCollection 2025.
6
Advances in AAV-mediated gene replacement therapy for pediatric monogenic neurological disorders.腺相关病毒介导的小儿单基因神经疾病基因替代疗法的进展
Mol Ther Methods Clin Dev. 2024 Oct 16;32(4):101357. doi: 10.1016/j.omtm.2024.101357. eCollection 2024 Dec 12.
7
GM1 gangliosidosis type II: Results of a 10-year prospective study.GM1 神经节苷脂贮积症 II 型:一项 10 年前瞻性研究的结果。
Genet Med. 2024 Jul;26(7):101144. doi: 10.1016/j.gim.2024.101144. Epub 2024 Apr 16.
8
GM1 Gangliosidosis Type II: Results of a 10-Year Prospective Study.II型GM1神经节苷脂贮积症:一项10年前瞻性研究的结果
medRxiv. 2024 Jan 4:2024.01.04.24300778. doi: 10.1101/2024.01.04.24300778.
9
Identification of genetic variants associated with a wide spectrum of phenotypes clinically diagnosed as Sanfilippo and Morquio syndromes using whole genome sequencing.利用全基因组测序鉴定与临床诊断为Sanfilippo综合征和Morquio综合征的广泛表型相关的基因变异。
Front Genet. 2023 Sep 11;14:1254909. doi: 10.3389/fgene.2023.1254909. eCollection 2023.
10
AAV-based in vivo gene therapy for neurological disorders.基于腺相关病毒的神经疾病体内基因治疗。
Nat Rev Drug Discov. 2023 Oct;22(10):789-806. doi: 10.1038/s41573-023-00766-7. Epub 2023 Sep 1.